Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,138 Cr
up ₹44.4 Cr vs Sep 2024
- Stocks held
- 29
- up 1 vs Sep 2024
- Top 10 weight
- 65.0%
- of the portfolio in its ten largest
- Cash & debt
- 2.7%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 16
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In October 2024 it disclosed 29 stocks worth ₹3,138 Cr, up ₹44.4 Cr from Sep 2024. Its largest positions were Sun Pharmaceutical Industries Limited (11.0%), Suven Pharmaceuticals Limited (10.8%), IPCA Laboratories Limited (8.1%); the ten largest together made up 65.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 66.4% of its equity. Cash and debt stood at 2.7%. Compared with Sep 2024 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
90%
Top-10 weight is higher than 90% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
39%
Holds more cash than 39% of peers
Holdings in October 2024
Download CSVEvery line the fund disclosed, with the change against Sep 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 11.05%
- Δ weight
- down 0.63 pts
- Value
- ₹347 Cr
- Δ value
- down ₹14.6 Cr
- Status
- Trimmed
- Weight
- 10.82%
- Δ weight
- up 1.02 pts
- Value
- ₹340 Cr
- Δ value
- up ₹36.3 Cr
- Status
- Added
- Weight
- 8.12%
- Δ weight
- up 0.35 pts
- Value
- ₹255 Cr
- Δ value
- up ₹14.5 Cr
- Status
- Added
- Weight
- 6.85%
- Δ weight
- down 0.56 pts
- Value
- ₹215 Cr
- Δ value
- down ₹14.2 Cr
- Status
- Trimmed
- Weight
- 5.38%
- Δ weight
- up 0.46 pts
- Value
- ₹169 Cr
- Δ value
- up ₹16.6 Cr
- Status
- Added
- Weight
- 5.30%
- Δ weight
- up 0.09 pts
- Value
- ₹166 Cr
- Δ value
- up ₹5.1 Cr
- Status
- Added
- Weight
- 5.12%
- Δ weight
- down 0.43 pts
- Value
- ₹161 Cr
- Δ value
- down ₹10.9 Cr
- Status
- Trimmed
- Weight
- 4.33%
- Δ weight
- up 2.26 pts
- Value
- ₹136 Cr
- Δ value
- up ₹71.9 Cr
- Status
- Added
- Weight
- 4.17%
- Δ weight
- down 0.17 pts
- Value
- ₹131 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 3.84%
- Δ weight
- down 3.89 pts
- Value
- ₹121 Cr
- Δ value
- down ₹119 Cr
- Status
- Trimmed
- Weight
- 3.41%
- Δ weight
- down 0.43 pts
- Value
- ₹107 Cr
- Δ value
- down ₹11.8 Cr
- Status
- Trimmed
- Weight
- 3.24%
- Δ weight
- up 0.08 pts
- Value
- ₹102 Cr
- Δ value
- up ₹4 Cr
- Status
- Added
- Weight
- 2.87%
- Δ weight
- up 0.06 pts
- Value
- ₹90.2 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 2.72%
- Δ weight
- down 0.56 pts
- Value
- ₹85.4 Cr
- Δ value
- down ₹16 Cr
- Status
- Trimmed
- Weight
- 2.65%
- Δ weight
- down 0.14 pts
- Value
- ₹83 Cr
- Δ value
- down ₹3.1 Cr
- Status
- Trimmed
- Weight
- 2.53%
- Δ weight
- up 0.04 pts
- Value
- ₹79.5 Cr
- Δ value
- up ₹2.3 Cr
- Status
- Added
- Weight
- 2.46%
- Δ weight
- down 0.18 pts
- Value
- ₹77.2 Cr
- Δ value
- down ₹4.4 Cr
- Status
- Trimmed
- Weight
- 2.34%
- Δ weight
- down 0.32 pts
- Value
- ₹73.5 Cr
- Δ value
- down ₹9 Cr
- Status
- Trimmed
- Weight
- 2.21%
- Δ weight
- up 2.21 pts
- Value
- ₹69.3 Cr
- Δ value
- up ₹69.3 Cr
- Status
- New
- Weight
- 1.95%
- Δ weight
- up 0.38 pts
- Value
- ₹61.2 Cr
- Δ value
- up ₹12.8 Cr
- Status
- Added
- Weight
- 1.57%
- Δ weight
- up 0.80 pts
- Value
- ₹49.3 Cr
- Δ value
- up ₹25.5 Cr
- Status
- Added
- Weight
- 1.47%
- Δ weight
- down 0.22 pts
- Value
- ₹46.3 Cr
- Δ value
- down ₹6.2 Cr
- Status
- Trimmed
- Weight
- 1.21%
- Δ weight
- up <0.01 pts
- Value
- ₹37.9 Cr
- Δ value
- up ₹65 L
- Status
- Added
- Weight
- 1.13%
- Δ weight
- down 0.09 pts
- Value
- ₹35.5 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 0.96%
- Δ weight
- down 0.02 pts
- Value
- ₹30.1 Cr
- Δ value
- down ₹6 L
- Status
- Held
- Weight
- 0.69%
- Δ weight
- down 0.04 pts
- Value
- ₹21.6 Cr
- Δ value
- down ₹1 Cr
- Status
- Trimmed
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.68%
- Δ weight
- down 0.07 pts
- Value
- ₹21.4 Cr
- Δ value
- down ₹1.7 Cr
- Status
- Trimmed
- Weight
- 0.41%
- Δ weight
- down 0.03 pts
- Value
- ₹13 Cr
- Δ value
- down ₹66 L
- Status
- Trimmed
- Weight
- 0.41%
- Δ weight
- down 0.01 pts
- Value
- ₹12.8 Cr
- Δ value
- down ₹7 L
- Status
- Trimmed
- Weight
- 0.07%
- Δ weight
- up 0.01 pts
- Value
- ₹2.3 Cr
- Δ value
- up ₹30 L
- Status
- Added
- Weight
- 0.03%
- Δ weight
- down <0.01 pts
- Value
- ₹100 L
- Δ value
- down ₹1 L
- Status
- Trimmed
What changed, Sep 2024 to Oct 2024
New New positions (1)
- Laurus Labs Limited2.2% · ₹69.3 Cr
Exited Exited (0)
None.
Added Biggest additions
- Gland Pharma Limitedup ₹71.9 Cr (+2.26% pts)
- Suven Pharmaceuticals Limitedup ₹36.3 Cr (+1.02% pts)
- Emcure Pharmaceuticals Limitedup ₹25.5 Cr (+0.80% pts)
- Illumina Incup ₹16.6 Cr (+0.46% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2024, the weight rose most in Healthcare Services (+0.3 pts) and Pharmaceuticals (+0.2 pts), and fell most in Pharmaceuticals & Biotechnology (−0.3 pts) and Insurance (−0.2 pts).
- Healthcare Services17.7% → 18.0%+0.3 pts
- Pharmaceuticals5.4% → 5.6%+0.2 pts
- Pharmaceuticals & Biotechnology66.7% → 66.4%−0.3 pts
- Insurance1.8% → 1.5%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2021 | Oct 2023 | Apr 2024 | Jul 2024 | Sep 2024 | Oct 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 58.7% | 73.3% | 71.6% | 69.7% | 66.7% | 66.4% |
| Healthcare Services | 25.4% | 11.7% | 14.0% | 14.6% | 17.7% | 18.0% |
| Healthcare Equipment & Supplies | 6.3% | 6.3% | 6.5% | 8.0% | 8.0% | 8.1% |
| Pharmaceuticals | 7.0% | 5.8% | 5.5% | 5.4% | 5.4% | 5.6% |
| Insurance | 2.5% | 2.0% | 1.8% | 1.8% | 1.8% | 1.5% |
| Retailing | — | 0.9% | 0.6% | 0.5% | 0.4% | 0.4% |
Allocation in Oct 2024change vs Sep 2024
- Pharmaceuticals & Biotechnology (14)66.4%▼ 0.3 pts
- Healthcare Services (8)18.0%▲ 0.3 pts
- Healthcare Equipment & Supplies (2)8.1%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Oct 2024
2.7%
▼ 0.6 pts vs Sep 2024
- Cash alone
- 2.7%
- cash and net receivables
- A year earlier
- 1.3%
- Oct 2023 · now ▲ 1.5 pts
- Last 12 months
- 0.9% – 5.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.